CRISPR/Cas: a Potential Gene-editing Tool in the Nervous System

Overview

Journal Cell Regen

Publisher Springer

Date 2020 Aug 8

PMID 32761306

Citations 4

Authors

Yanxia Gao

Kexin Gao

Hui Yang

Affiliations

Soon will be listed here.

Abstract

The rapidly developmental RNA-guided CRISPR/Cas system is a powerful tool for RNA and DNA editing in a variety of cells from different species and makes a great contribution to gene function research, disease model generation and gene therapy development in the past few years. The ease of use, low cost and high efficiency of CRISPR/Cas make it commonly used in various conditions. In this review, we introduce the CRISPR/Cas system and its diverse applications in nervous system briefly, which provides a better understanding for its potential application values.

Citing Articles

Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.

Srivastava P, Kim K Pharmaceutics. 2022; 14(11).

PMID: 36365188 PMC: 9692612. DOI: 10.3390/pharmaceutics14112370.

CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives.

Chen G, Wei T, Yang H, Li G, Li H Cells. 2022; 11(19).

PMID: 36230926 PMC: 9564082. DOI: 10.3390/cells11192964.

The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases.

Lou J, Wang B, Li J, Ni P, Jin Y, Chen S Mol Biol Rep. 2022; 49(12):11301-11311.

PMID: 35857175 PMC: 9297709. DOI: 10.1007/s11033-022-07752-z.

Correction to: CRISPR/Cas: a potential gene-editing tool in the nervous system.

Gao Y, Gao K, Yang H Cell Regen. 2021; 10(1):35.

PMID: 34643819 PMC: 8514586. DOI: 10.1186/s13619-021-00095-3.

References

Mandegar M, Huebsch N, Frolov E, Shin E, Truong A, Olvera M . CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. Cell Stem Cell. 2016; 18(4):541-53. PMC: 4830697. DOI: 10.1016/j.stem.2016.01.022. View

Zetsche B, Heidenreich M, Mohanraju P, Fedorova I, Kneppers J, DeGennaro E . Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol. 2016; 35(1):31-34. PMC: 5225075. DOI: 10.1038/nbt.3737. View

Zentner G, Henikoff S . Epigenome editing made easy. Nat Biotechnol. 2015; 33(6):606-7. DOI: 10.1038/nbt.3248. View

Zuo E, Cai Y, Li K, Wei Y, Wang B, Sun Y . One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs. Cell Res. 2017; 27(7):933-945. PMC: 5518993. DOI: 10.1038/cr.2017.81. View

Liu J, Gao C, Chen W, Ma W, Li X, Shi Y . CRISPR/Cas9 facilitates investigation of neural circuit disease using human iPSCs: mechanism of epilepsy caused by an SCN1A loss-of-function mutation. Transl Psychiatry. 2016; 6:e703. PMC: 5068877. DOI: 10.1038/tp.2015.203. View

Kalebic N, Taverna E, Tavano S, Wong F, Suchold D, Winkler S . CRISPR/Cas9-induced disruption of gene expression in mouse embryonic brain and single neural stem cells in vivo. EMBO Rep. 2016; 17(3):338-48. PMC: 4772980. DOI: 10.15252/embr.201541715. View

Du M, Jillette N, Zhu J, Li S, Cheng A . CRISPR artificial splicing factors. Nat Commun. 2020; 11(1):2973. PMC: 7293279. DOI: 10.1038/s41467-020-16806-4. View

Pickar-Oliver A, Gersbach C . The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019; 20(8):490-507. PMC: 7079207. DOI: 10.1038/s41580-019-0131-5. View

Shao J, Wang M, Yu G, Zhu S, Yu Y, Heng B . Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation. Proc Natl Acad Sci U S A. 2018; 115(29):E6722-E6730. PMC: 6055150. DOI: 10.1073/pnas.1802448115. View

10.

La Russa M, Qi L . The New State of the Art: Cas9 for Gene Activation and Repression. Mol Cell Biol. 2015; 35(22):3800-9. PMC: 4609748. DOI: 10.1128/MCB.00512-15. View

11.

Kim D, Kim J, Hur J, Been K, Yoon S, Kim J . Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat Biotechnol. 2016; 34(8):863-8. DOI: 10.1038/nbt.3609. View

12.

Schilling G, Becher M, Sharp A, Jinnah H, Duan K, Kotzuk J . Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet. 1999; 8(3):397-407. DOI: 10.1093/hmg/8.3.397. View

13.

Ehrnhoefer D, Butland S, Pouladi M, Hayden M . Mouse models of Huntington disease: variations on a theme. Dis Model Mech. 2009; 2(3-4):123-9. PMC: 2650190. DOI: 10.1242/dmm.002451. View

14.

Dugar G, Leenay R, Eisenbart S, Bischler T, Aul B, Beisel C . CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9. Mol Cell. 2018; 69(5):893-905.e7. PMC: 5859949. DOI: 10.1016/j.molcel.2018.01.032. View

15.

Hou Z, Zhang Y, Propson N, Howden S, Chu L, Sontheimer E . Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A. 2013; 110(39):15644-9. PMC: 3785731. DOI: 10.1073/pnas.1313587110. View

16.

Zhang C, Konermann S, Brideau N, Lotfy P, Wu X, Novick S . Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d. Cell. 2018; 175(1):212-223.e17. PMC: 6179368. DOI: 10.1016/j.cell.2018.09.001. View

17.

Chavez A, Scheiman J, Vora S, Pruitt B, Tuttle M, Iyer E . Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 2015; 12(4):326-8. PMC: 4393883. DOI: 10.1038/nmeth.3312. View

18.

Li J, Lin X, Tang C, Lu Y, Hu X, Zuo E . Disruption of splicing-regulatory elements using CRISPR/Cas9 to rescue spinal muscular atrophy in human iPSCs and mice. Natl Sci Rev. 2021; 7(1):92-101. PMC: 8446915. DOI: 10.1093/nsr/nwz131. View

19.

Ortiz-Virumbrales M, Moreno C, Kruglikov I, Marazuela P, Sproul A, Jacob S . CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 neurons. Acta Neuropathol Commun. 2017; 5(1):77. PMC: 5660456. DOI: 10.1186/s40478-017-0475-z. View

20.

Komor A, Kim Y, Packer M, Zuris J, Liu D . Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016; 533(7603):420-4. PMC: 4873371. DOI: 10.1038/nature17946. View